Page 138 - JSOM Winter 2018
P. 138

32.  Petroczi A, Taylor G, Naughton DP. Mission impossible? Regu-  46.  Chatham-Stephens K, Taylor E, Chang A, et al. Hepatotoxicity
             latory and enforcement issues to ensure safety of dietary supple-  associated with weight loss or sports dietary supplements, includ-
             ments. Food Chem Toxicol. 2011;49(2):393–402.      ing OxyELITE Pro-United States, 2013. Drug Test Anal. 2017;9
          33.  Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical com-  (1):68–74.
             position and labeling of substances marketed as selective  an-  47.  Eliason MJ, Eichner A, Cancio A, et al. Case reports: death of
             drogen receptor modulators and sold via the Internet.  JAMA.   active duty soldiers following ingestion of dietary supplements
             2017;318(20):2004–2010.                            containing 1,3-dimethylamylamine (DMAA).  Mil Med.  2012;
          34.  Pawar RS,  Grundel E. Overview  of regulation  of dietary  sup-  177(12):1455–1459.
             plements in the USA and issues of adulteration with phenethyl-  48.  Pascale B, Steele C, Attipoe S, et al. Dietary supplements:
             amines (PEAs). Drug Test Anal. 2017;9(3):500–517.  knowledge and adverse event reporting among American Med-
          35.  US Food and Drug Administration. Tainted products marketed   ical Society for Sports Medicine Physicians.  Clin J Sport Med.
             as dietary supplements_CDER.  https://www.accessdata.fda.gov   2016;26(2):139–144.
             /scripts/sda/sdNavigation.cfm?filter=&sortColumn=1d&sd=   49.  Cellini M, Attipoe S, Seales P, et al. Dietary supplements: physi-
             tainted_supplements_cder&displayAll=false&page=1. Accessed 14    cian knowledge and adverse event reporting. Med Sci Sports Ex-
             October 2018.                                      erc. 2013;45(1):23–28.
          36.  Geyer H,  Parr MK,  Koehler K, et  al. Nutritional  supplements   50.  Lobb A. Enhancing FDA’s post-market surveillance of dietary
             cross-contaminated and faked with doping substances.  J Mass   supplements: two simple steps to build capacity.  J Diet Suppl.
             Spectrom. 2008;43(7):892–902.                      2009;6(3):204–210.
          37.  Judkins CM, Teale P, Hall DJ. The role of banned substance resi-  51.  Ioannidis JPA, Trepanowski JF. Disclosures in nutrition research:
             due analysis in the control of dietary supplement contamination.   why it is different. JAMA. 2018;319(6):547–548.
             Drug Test Anal. 2010;2(9):417–420.              52.  Margetts B. Stopping the rot in nutrition science. Public Health
          38.  Green GA, Catlin DH, Starcevic B. Analysis of over-the-counter   Nutr. 2006;9(2):169–173.
             dietary supplements. Clin J Sport Med. 2001;11(4):254–259.  53.  US Food and Drug Administration. Voluntary third-party certifica-
          39.  Parr MK, Geyer H, Hoffmann B, et al. High amounts of 17-meth-  tion programs for foods and feeds; guidance for industry—volun-
             ylated anabolic-androgenic steroids in effervescent tablets on   tary third-party certification programs for foods and feeds. 2009.
             the dietary supplement market.  Biomed Chromatogr.  2007;21   http://www.fda.gov/RegulatoryInformation/Guidances/ucm125
             (2):164–168.                                       431.htm. Accessed 28 March 2012.
          40.  Knapik JJ, Trone DW, Austin KG, et al. Prevalence, adverse   54.  Sax JK. Dietary supplements are not all safe and not all food: how
             events, and factors associated with dietary supplement and nutri-  the low cost of dietary supplements preys on the consumer. Am J
             tional supplement use by US Navy and Marine Corps personnel.   Law Med. 2015;41(2-3):374–394.
             J Acad Nutr Diet. 2016;116(9):1423–1442.        55.  Cancio  A, Eliason MJ, Mercer J, et al. Third-party  certifica-
          41.  Burke J, Seda G, Allen D, et al. A case of severe exercise-induced   tion of dietary supplements: prevalence and concerns. Mil Med.
             rhabdomyolysis associated with a weight-loss dietary supple-  2012;177(12):1460–1463.
             ment. Mil Med. 2007;172(6):656–658.             56.  Shenkar J, Griffiths JC. Industry actions to address quality issues
          42.  Jones FJ, Andrews AH. Acute liver injury associated with the   for dietary supplements, botanicals, and other natural products.
             herbal supplement hydroxycut in a soldier deployed to Iraq. Am   Clin Pharmacol Ther. 2018;104(3):423–425.
             J Gastroenterol. 2007;102(10):2357–2358.        57.  Jordan SA, Jack SA, Pless RP. Safety surveillance of dietary sup-
          43.  Hughes J, Shelton B, Hughes T. Suspected dietary supplement   plements: importance, challenges, and new horizons. Clin Phar-
             injuries in special operations soldiers. J Spec Oper Med. 2010;   macol Ther. 2018;104(3):432–434.
             10(3):14–24.                                    58.  Deuster PA, Lindsey AT, Scott JM. Dietary supplements: regu-
          44.  Oh RC, Henning JS. Exertional heatstroke in an infantry soldier   latory challenges and issues in the Department of Defense. Mil
             taking ephedra-containing dietary supplements. Mil Med. 2003;   Med. 2018;183(3-4):53–55.
             168(6):429–430.
          45.  Magee CD, Witte S, Kwok RM, et al. Mission compromised?
             Drug-induced liver injury from prohormone supplements con-
             taining anabolic-androgenic steroids in two deployed U.S. Service
             Members. Mil Med. 2016;181(9):e1169–1171.


































          136  |  JSOM   Volume 18, Edition 4 / Winter 2018
   133   134   135   136   137   138   139   140   141   142   143